Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

Por Chanan-Khan Asher A, Calinski Diane, Ling Xiang, Zhou Muxiang, Li Fengzhi
Publicado em 2010-01-01

Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

Por Ling, Xiang, Calinski, Diane, Chanan-Khan, Asher A, Zhou, Muxiang, Li, Fengzhi
Publicado em 2010

Development of target-specific treatments in multiple myeloma

Por Chanan-Khan, Asher A., Borrello, Ivan, Lee, Kelvin P., Reece, Donna E.
Publicado em 2010

Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma

Por Stewart, A. Keith, Jacobus, Susanna, Fonseca, Rafael, Weiss, Matthias, Callander, Natalie S., Chanan-Khan, Asher A., Rajkumar, S. Vincent
Publicado no Blood (2015)

Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study

Por Richardson, Paul G., Chanan-Khan, Asher A., Alsina, Melissa, Albitar, Maher, Berman, David, Messina, Marianne, Mitsiades, Constantine S., Anderson, Kenneth C.
Publicado em 2010

Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma

Por Chanan-Khan, Asher A., Lonial, Sagar, Weber, Donna, Borrello, Ivan, Foá, Robin, Hellmann, Andrzej, Dimopoulos, Meletios, Swern, Arlene S., Knight, Robert
Publicado em 2012

Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications

Por Paulus, Aneel, Chitta, Kasyapa S., Wallace, Paul K., Advani, Pooja P., Akhtar, Sharoon, Kuranz-Blake, Maja, Ailawadhi, Sikander, Chanan-Khan, Asher A.
Publicado no PLoS One (2015)

Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells

Por Rozanski, Cheryl H., Arens, Ramon, Carlson, Louise M., Nair, Jayakumar, Boise, Lawrence H., Chanan-Khan, Asher A., Schoenberger, Stephen P., Lee, Kelvin P.
Publicado em 2011

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes

Por Swaika, Abhisek, Frank, Ryan D., Yang, Dongyun, Finn, Laura E., Jiang, Liuyan, Advani, Pooja, Chanan‐Khan, Asher A., Ailawadhi, Sikander, Foran, James M.
Publicado no Cancer Med (2017)

Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis

Por BAZ, RACHID, PATEL, MEHUL, FINLEY-OLIVER, ELIZABETH, LEBOVIC, DANIEL, HUSSEIN, MOHAMAD A., MILLER, KENA C., WOOD, MARGARET, SHER, TAIMUR, LEE, KELVIN, CHANAN-KHAN, ASHER A.
Publicado em 2010

Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström Macroglobulinemia

Por Gaudette, Brian T., Dwivedi, Bhakti, Chitta, Kasyapa S., Poulain, Stéphanie, Powell, Doris, Vertino, Paula, Leleu, Xavier, Lonial, Sagar, Chanan-Khan, Asher A., Kowalski, Jeanne, Boise, Lawrence H.
Publicado no Oncogene (2015)

Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre...

Por Voorhees, Peter M., Orlowski, Robert Z., Mulkey, Flora, Watson, Peter, Geyer, Susan, Sanford, Ben L., Bennett, Elizabeth, Chanan-Khan, Asher A., Bloomfield, Clara D., Larson, Richard A.
Publicado no Br J Haematol (2015)

Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and...

Por Chanan-Khan, Asher A., Chitta, Kasyapa, Ersing, Noreen, Paulus, Aneel, Masood, Aisha, Sher, Taimur, Swaika, Abhisek, Wallace, Paul K., Mashtare, Terry L., Wilding, Greg, Lee, Kelvin, Czuczman, Myron S., Borrello, Ivan, Bangia, Naveen
Publicado em 2011

5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimerse...

Por O'Brien, Susan, Moore, Joseph O., Boyd, Thomas E., Larratt, Loree M., Skotnicki, Aleksander B., Koziner, Benjamin, Chanan-Khan, Asher A., Seymour, John F., Gribben, John, Itri, Loretta M., Rai, Kanti R.
Publicado no J Clin Oncol (2009)

Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1

Por Richardson, Paul G., Zimmerman, Todd M., Hofmeister, Craig C., Talpaz, Moshe, Chanan-Khan, Asher A., Kaufman, Jonathan L., Laubach, Jacob P., Chauhan, Dharminder, Jakubowiak, Andrzej J., Reich, Steven, Trikha, Mohit, Anderson, Kenneth C.
Publicado no Blood (2016)

Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma

Por Kuhn, Deborah J., Chen, Qing, Voorhees, Peter M., Strader, John S., Shenk, Kevin D., Sun, Congcong M., Demo, Susan D., Bennett, Mark K., van Leeuwen, Fijs W. B., Chanan-Khan, Asher A., Orlowski, Robert Z.
Publicado em 2007

Hypogammaglobulinemia in Newly Diagnosed Chronic Lymphocytic Leukemia: Natural History, Clinical Correlates and Outcomes

Por Parikh, Sameer A., Leis, Jose F., Chaffee, Kari G., Call, Timothy G., Hanson, Curtis A., Ding, Wei, Chanan-Khan, Asher A., Bowen, Deborah, Conte, Michael, Schwager, Susan, Slager, Susan L., Van Dyke, Daniel L., Jelinek, Diane F., Kay, Neil E., Shanafelt, Tait D.
Publicado no Cancer (2015)

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER‐medicare analysis

Por Ailawadhi, Sikander, Frank, Ryan D., Advani, Pooja, Swaika, Abhisek, Temkit, M'hamed, Menghani, Richa, Sharma, Mayank, Meghji, Zahara, Paulus, Shumail, Khera, Nandita, Hashmi, Shahrukh K., Paulus, Aneel, Kakar, Tanya S., Hodge, David O., Colibaseanu, Dorin T., Vizzini, Michael R., Roy, Vivek, Colon‐Otero, Gerardo, Chanan‐Khan, Asher A.
Publicado no Cancer Med (2017)

Development and characterization of a novel human Waldenström Macroglobulinemia cell line (RPCI-WM1; Roswell Park Cancer Institute-Waldenström Macroglobulinemia 1)

Por Chitta, Kasyapa S., Paulus, Aneel, Ailawadhi, Sikander, Foster, Barbara A., Moser, Michael T., Starostik, Petr, Masood, Aisha, Sher, Taimur, Miller, Kena C., Iancu, Dan M., Conroy, Jeffrey, Nowak, Norma J., Sait, Sheila N., Personett, David A., Coleman, Morton, Furman, Richard R., Martin, Peter, Ansell, Stephen M., Lee, Kelvin, Chanan-Khan, Asher A.
Publicado no Leuk Lymphoma (2012)

Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy

Por Richardson, Paul G., Xie, Wanling, Mitsiades, Constantine, Chanan-Khan, Asher A., Lonial, Sagar, Hassoun, Hani, Avigan, David E., Oaklander, Anne Louise, Kuter, David J., Wen, Patrick Y., Kesari, Santosh, Briemberg, Hannah R., Schlossman, Robert L., Munshi, Nikhil C., Heffner, L. Thompson, Doss, Deborah, Esseltine, Dixie-Lee, Weller, Edie, Anderson, Kenneth C., Amato, Anthony A.
Publicado em 2009